← 產業報告目錄
Network Point-of-Care Glucose Testing Device Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 131報告編號 APO-bddbe5a32f
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Network Point-of-Care Glucose Testing Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Network Point-of-Care Glucose Testing Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Network Point-of-Care Glucose Testing Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Network Point-of-Care Glucose Testing Device include Johnson & Johnson, Trividia Health, Inc., Terumo, Roche Holding AG, Prodigy Diabetes Care, Panasonic Healthcare Holdings, Omron, Nova Biomedical and Nipro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Network Point-of-Care Glucose Testing Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Network Point-of-Care Glucose Testing Device Market by Company
Johnson & Johnson
Trividia Health, Inc.
Terumo
Roche Holding AG
Prodigy Diabetes Care
Panasonic Healthcare Holdings
Omron
Nova Biomedical
Nipro
LifeScan, Inc.
EKF Diagnostics
Danaher Corporation
B. Braun
Ascensia Diabetes Care Holdings AG
AgaMatrix
ACON Laboratories, Inc.
77 Elektronika
Network Point-of-Care Glucose Testing Device Segment by Type
0.5uL/0.6uL
1.5uL
1uL
Others
Network Point-of-Care Glucose Testing Device Segment by Application
Clinic
Hospital
Household
Network Point-of-Care Glucose Testing Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Network Point-of-Care Glucose Testing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Network Point-of-Care Glucose Testing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Network Point-of-Care Glucose Testing Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Network Point-of-Care Glucose Testing Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Network Point-of-Care Glucose Testing Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Network Point-of-Care Glucose Testing Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Network Point-of-Care Glucose Testing Device Market Size (2021-2032)
2.2.2 Global Network Point-of-Care Glucose Testing Device Sales (2021-2032)
2.2.3 Global Network Point-of-Care Glucose Testing Device Market Average Price (2021-2032)
2.3 Network Point-of-Care Glucose Testing Device by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 0.5uL/0.6uL
2.3.3 1.5uL
2.3.4 1uL
2.3.5 Others
2.4 Network Point-of-Care Glucose Testing Device by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Clinic
2.4.3 Hospital
2.4.4 Household
3 Market Competitive Landscape by Manufacturers
3.1 Global Network Point-of-Care Glucose Testing Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Network Point-of-Care Glucose Testing Device Sales (k units) of Manufacturers (2021-2026)
3.3 Global Network Point-of-Care Glucose Testing Device Revenue of Manufacturers (2021-2026)
3.4 Global Network Point-of-Care Glucose Testing Device Average Price by Manufacturers (2021-2026)
3.5 Global Network Point-of-Care Glucose Testing Device Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Product Type & Application
3.8 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Established Date
3.9 Global Network Point-of-Care Glucose Testing Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson Company Information
4.1.2 Johnson & Johnson Business Overview
4.1.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
4.1.5 Johnson & Johnson Recent Developments
4.2 Trividia Health, Inc.
4.2.1 Trividia Health, Inc. Company Information
4.2.2 Trividia Health, Inc. Business Overview
4.2.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
4.2.5 Trividia Health, Inc. Recent Developments
4.3 Terumo
4.3.1 Terumo Company Information
4.3.2 Terumo Business Overview
4.3.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
4.3.5 Terumo Recent Developments
4.4 Roche Holding AG
4.4.1 Roche Holding AG Company Information
4.4.2 Roche Holding AG Business Overview
4.4.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
4.4.5 Roche Holding AG Recent Developments
4.5 Prodigy Diabetes Care
4.5.1 Prodigy Diabetes Care Company Information
4.5.2 Prodigy Diabetes Care Business Overview
4.5.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
4.5.5 Prodigy Diabetes Care Recent Developments
4.6 Panasonic Healthcare Holdings
4.6.1 Panasonic Healthcare Holdings Company Information
4.6.2 Panasonic Healthcare Holdings Business Overview
4.6.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
4.6.5 Panasonic Healthcare Holdings Recent Developments
4.7 Omron
4.7.1 Omron Company Information
4.7.2 Omron Business Overview
4.7.3 Omron Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Omron Network Point-of-Care Glucose Testing Device Product Portfolio
4.7.5 Omron Recent Developments
4.8 Nova Biomedical
4.8.1 Nova Biomedical Company Information
4.8.2 Nova Biomedical Business Overview
4.8.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
4.8.5 Nova Biomedical Recent Developments
4.9 Nipro
4.9.1 Nipro Company Information
4.9.2 Nipro Business Overview
4.9.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
4.9.5 Nipro Recent Developments
4.10 LifeScan, Inc.
4.10.1 LifeScan, Inc. Company Information
4.10.2 LifeScan, Inc. Business Overview
4.10.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.10.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
4.10.5 LifeScan, Inc. Recent Developments
4.11 EKF Diagnostics
4.11.1 EKF Diagnostics Company Information
4.11.2 EKF Diagnostics Business Overview
4.11.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.11.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
4.11.5 EKF Diagnostics Recent Developments
4.12 Danaher Corporation
4.12.1 Danaher Corporation Company Information
4.12.2 Danaher Corporation Business Overview
4.12.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
4.12.5 Danaher Corporation Recent Developments
4.13 B. Braun
4.13.1 B. Braun Company Information
4.13.2 B. Braun Business Overview
4.13.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.13.4 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
4.13.5 B. Braun Recent Developments
4.14 Ascensia Diabetes Care Holdings AG
4.14.1 Ascensia Diabetes Care Holdings AG Company Information
4.14.2 Ascensia Diabetes Care Holdings AG Business Overview
4.14.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
4.14.5 Ascensia Diabetes Care Holdings AG Recent Developments
4.15 AgaMatrix
4.15.1 AgaMatrix Company Information
4.15.2 AgaMatrix Business Overview
4.15.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.15.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
4.15.5 AgaMatrix Recent Developments
4.16 ACON Laboratories, Inc.
4.16.1 ACON Laboratories, Inc. Company Information
4.16.2 ACON Laboratories, Inc. Business Overview
4.16.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.16.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
4.16.5 ACON Laboratories, Inc. Recent Developments
4.17 77 Elektronika
4.17.1 77 Elektronika Company Information
4.17.2 77 Elektronika Business Overview
4.17.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
4.17.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
4.17.5 77 Elektronika Recent Developments
5 Global Network Point-of-Care Glucose Testing Device Market Scenario by Region
5.1 Global Network Point-of-Care Glucose Testing Device Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021-2032
5.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021-2026
5.2.2 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2027-2032
5.3 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2021-2032
5.3.1 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2021-2026
5.3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2027-2032
5.4 North America Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
5.4.1 North America Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
5.4.3 North America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
5.5.1 Europe Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
5.5.3 Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
5.6.1 Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
5.6.3 Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
5.7.1 South America Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
5.7.3 South America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
5.8.3 Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032)
6.1.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032) & (k units)
6.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2032)
6.2 Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021-2032)
6.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2032)
6.3 Global Network Point-of-Care Glucose Testing Device Price by Type (2021-2032)
7 Segment by Application
7.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032)
7.1.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032) & (k units)
7.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2032)
7.2 Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021-2032)
7.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2032)
7.3 Global Network Point-of-Care Glucose Testing Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Network Point-of-Care Glucose Testing Device Value Chain Analysis
8.1.1 Network Point-of-Care Glucose Testing Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Network Point-of-Care Glucose Testing Device Production Mode & Process
8.2 Network Point-of-Care Glucose Testing Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Network Point-of-Care Glucose Testing Device Distributors
8.2.3 Network Point-of-Care Glucose Testing Device Customers
9 Global Network Point-of-Care Glucose Testing Device Analyzing Market Dynamics
9.1 Network Point-of-Care Glucose Testing Device Industry Trends
9.2 Network Point-of-Care Glucose Testing Device Industry Drivers
9.3 Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
9.4 Network Point-of-Care Glucose Testing Device Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Network Point-of-Care Glucose Testing Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Network Point-of-Care Glucose Testing Device Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Network Point-of-Care Glucose Testing Device Revenue of Manufacturers (2021-2026)
Table 9. Global Network Point-of-Care Glucose Testing Device Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Network Point-of-Care Glucose Testing Device Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Network Point-of-Care Glucose Testing Device Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Network Point-of-Care Glucose Testing Device, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Network Point-of-Care Glucose Testing Device, Product Type & Application
Table 14. Global Network Point-of-Care Glucose Testing Device Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Network Point-of-Care Glucose Testing Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Johnson & Johnson Company Information
Table 19. Johnson & Johnson Business Overview
Table 20. Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
Table 22. Johnson & Johnson Recent Developments
Table 23. Trividia Health, Inc. Company Information
Table 24. Trividia Health, Inc. Business Overview
Table 25. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 27. Trividia Health, Inc. Recent Developments
Table 28. Terumo Company Information
Table 29. Terumo Business Overview
Table 30. Terumo Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
Table 32. Terumo Recent Developments
Table 33. Roche Holding AG Company Information
Table 34. Roche Holding AG Business Overview
Table 35. Roche Holding AG Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
Table 37. Roche Holding AG Recent Developments
Table 38. Prodigy Diabetes Care Company Information
Table 39. Prodigy Diabetes Care Business Overview
Table 40. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
Table 42. Prodigy Diabetes Care Recent Developments
Table 43. Panasonic Healthcare Holdings Company Information
Table 44. Panasonic Healthcare Holdings Business Overview
Table 45. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
Table 47. Panasonic Healthcare Holdings Recent Developments
Table 48. Omron Company Information
Table 49. Omron Business Overview
Table 50. Omron Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Omron Network Point-of-Care Glucose Testing Device Product Portfolio
Table 52. Omron Recent Developments
Table 53. Nova Biomedical Company Information
Table 54. Nova Biomedical Business Overview
Table 55. Nova Biomedical Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
Table 57. Nova Biomedical Recent Developments
Table 58. Nipro Company Information
Table 59. Nipro Business Overview
Table 60. Nipro Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
Table 62. Nipro Recent Developments
Table 63. LifeScan, Inc. Company Information
Table 64. LifeScan, Inc. Business Overview
Table 65. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 67. LifeScan, Inc. Recent Developments
Table 68. EKF Diagnostics Company Information
Table 69. EKF Diagnostics Business Overview
Table 70. EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
Table 72. EKF Diagnostics Recent Developments
Table 73. Danaher Corporation Company Information
Table 74. Danaher Corporation Business Overview
Table 75. Danaher Corporation Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
Table 77. Danaher Corporation Recent Developments
Table 78. B. Braun Company Information
Table 79. B. Braun Business Overview
Table 80. B. Braun Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
Table 82. B. Braun Recent Developments
Table 83. Ascensia Diabetes Care Holdings AG Company Information
Table 84. Ascensia Diabetes Care Holdings AG Business Overview
Table 85. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
Table 87. Ascensia Diabetes Care Holdings AG Recent Developments
Table 88. AgaMatrix Company Information
Table 89. AgaMatrix Business Overview
Table 90. AgaMatrix Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
Table 92. AgaMatrix Recent Developments
Table 93. ACON Laboratories, Inc. Company Information
Table 94. ACON Laboratories, Inc. Business Overview
Table 95. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 97. ACON Laboratories, Inc. Recent Developments
Table 98. 77 Elektronika Company Information
Table 99. 77 Elektronika Business Overview
Table 100. 77 Elektronika Network Point-of-Care Glucose Testing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
Table 102. 77 Elektronika Recent Developments
Table 103. Global Network Point-of-Care Glucose Testing Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 104. Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2026) & (k units)
Table 105. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2021-2026)
Table 106. Global Network Point-of-Care Glucose Testing Device Sales by Region (2027-2032) & (k units)
Table 107. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2027-2032)
Table 108. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2021-2026) & (US$ Million)
Table 109. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2021-2026)
Table 110. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2027-2032) & (US$ Million)
Table 111. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2027-2032)
Table 112. North America Network Point-of-Care Glucose Testing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. North America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 114. North America Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 115. North America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2026) & (US$ Million)
Table 116. North America Network Point-of-Care Glucose Testing Device Revenue by Country (2027-2032) & (US$ Million)
Table 117. Europe Network Point-of-Care Glucose Testing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 119. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 120. Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2026) & (US$ Million)
Table 121. Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2027-2032) & (US$ Million)
Table 122. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 124. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 125. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2026) & (US$ Million)
Table 126. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Country (2027-2032) & (US$ Million)
Table 127. South America Network Point-of-Care Glucose Testing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. South America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 129. South America Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 130. South America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2026) & (US$ Million)
Table 131. South America Network Point-of-Care Glucose Testing Device Revenue by Country (2027-2032) & (US$ Million)
Table 132. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 134. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 135. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2026) & (US$ Million)
Table 136. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2027-2032) & (US$ Million)
Table 137. Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2026) & (k units)
Table 138. Global Network Point-of-Care Glucose Testing Device Sales by Type (2027-2032) & (k units)
Table 139. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2026)
Table 140. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2027-2032)
Table 141. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021-2026) & (US$ Million)
Table 142. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2027-2032) & (US$ Million)
Table 143. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2026)
Table 144. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2027-2032)
Table 145. Global Network Point-of-Care Glucose Testing Device Price by Type (2021-2026) & (USD/unit)
Table 146. Global Network Point-of-Care Glucose Testing Device Price by Type (2027-2032) & (USD/unit)
Table 147. Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2026) & (k units)
Table 148. Global Network Point-of-Care Glucose Testing Device Sales by Application (2027-2032) & (k units)
Table 149. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2026)
Table 150. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2027-2032)
Table 151. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021-2026) & (US$ Million)
Table 152. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2027-2032) & (US$ Million)
Table 153. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2026)
Table 154. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2027-2032)
Table 155. Global Network Point-of-Care Glucose Testing Device Price by Application (2021-2026) & (USD/unit)
Table 156. Global Network Point-of-Care Glucose Testing Device Price by Application (2027-2032) & (USD/unit)
Table 157. Key Raw Materials
Table 158. Raw Materials Key Suppliers
Table 159. Network Point-of-Care Glucose Testing Device Distributors List
Table 160. Network Point-of-Care Glucose Testing Device Customers List
Table 161. Network Point-of-Care Glucose Testing Device Industry Trends
Table 162. Network Point-of-Care Glucose Testing Device Industry Drivers
Table 163. Network Point-of-Care Glucose Testing Device Industry Restraints
Table 164. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Network Point-of-Care Glucose Testing Device Product Image
Figure 5. Global Network Point-of-Care Glucose Testing Device Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Network Point-of-Care Glucose Testing Device Market Size (2021-2032) & (US$ Million)
Figure 7. Global Network Point-of-Care Glucose Testing Device Sales (2021-2032) & (k units)
Figure 8. Global Network Point-of-Care Glucose Testing Device Average Price (USD/unit) & (2021-2032)
Figure 9. 0.5uL/0.6uL Product Image
Figure 10. 1.5uL Product Image
Figure 11. 1uL Product Image
Figure 12. Others Product Image
Figure 13. Clinic Product Image
Figure 14. Hospital Product Image
Figure 15. Household Product Image
Figure 16. Global Network Point-of-Care Glucose Testing Device Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Network Point-of-Care Glucose Testing Device, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Network Point-of-Care Glucose Testing Device Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Network Point-of-Care Glucose Testing Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Network Point-of-Care Glucose Testing Device Sales by Region in 2025
Figure 22. Global Network Point-of-Care Glucose Testing Device Revenue by Region in 2025
Figure 23. North America Network Point-of-Care Glucose Testing Device Market Size by Country in 2025
Figure 24. North America Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 25. North America Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2021-2032)
Figure 26. United States Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Network Point-of-Care Glucose Testing Device Market Size by Country in 2025
Figure 30. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 31. Europe Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2021-2032)
Figure 32. Germany Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Country in 2025
Figure 43. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2021-2032)
Figure 45. China Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Network Point-of-Care Glucose Testing Device Market Size by Country in 2025
Figure 54. South America Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 55. South America Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Country in 2025
Figure 60. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Network Point-of-Care Glucose Testing Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2032)
Figure 68. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2032)
Figure 69. Global Network Point-of-Care Glucose Testing Device Price (USD/unit) by Type (2021-2032)
Figure 70. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2032)
Figure 71. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2032)
Figure 72. Global Network Point-of-Care Glucose Testing Device Price (USD/unit) by Application (2021-2032)
Figure 73. Network Point-of-Care Glucose Testing Device Value Chain
Figure 74. Network Point-of-Care Glucose Testing Device Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
提及公司
Johnson & JohnsonTrividia Health, Inc.TerumoRoche Holding AGProdigy Diabetes CarePanasonic Healthcare HoldingsOmronNova BiomedicalNiproLifeScan, Inc.EKF DiagnosticsDanaher CorporationB. BraunAscensia Diabetes Care Holdings AGAgaMatrixACON Laboratories, Inc.77 Elektronika
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們